The Single Ventricle Reconstruction (SVR) trial, sponsored by the National Heart, Lung, and Blood Institute/Pediatric Heart Network (principal investigator: Richard G. Ohye, MD), is the first ...

Babies born with otherwise-lethal single ventricle heart defects can gain decades of life from early surgical intervention, but their lives are still fraught with medical complications that ...

LGVN READ THE FULL LGVN RESEARCH REPORT Longeveron (NASDAQ:LGVN) is a company that should be getting more attention from investors and the just released annual results again proved that point. LGVN ...